News
Garber Announces Advisory Committee for Harvard Law School Dean Search
News
First Harvard Prize Book in Kosovo Established by Harvard Alumni
News
Ryan Murdock ’25 Remembered as Dedicated Advocate and Caring Friend
News
Harvard Faculty Appeal Temporary Suspensions From Widener Library
News
Man Who Managed Clients for High-End Cambridge Brothel Network Pleads Guilty
Harvard students will be offered a unique chance to save lives through the Harvard-Radcliffe bone marrow drive, to be held tomorrow from 11 p.m. to 3 p.m. in the Green Room of Loker Commons.
Organized by the Harvard-Radcliffe Cancer Society, the drive will allow students to be added to the national bone marrow registry, after a simple blood test. The list identifies possible bone marrow transplants for patients suffering from leukemia.
According to Brendan. A Harley '00, co-director of the effort, leukemia patients suffer a loss of bone marrow when subjected to the heavy doses of radiation needed for treatment. Such patients can receive a transplant from family members of strangers but identifying donors with a correct genetic match can be difficult or even impossible.
"The bone marrow registry isn't complete," Harley said. "They don't have all of the genetic markers represented."
According to Harley, the problem is especially acute among minority groups.
"Many minority groups are under represented on the list, so the chances for finding a match are even lower," Harley said. "Everyone is encouraged to come, but minorities are especially encouraged to come because there's a greater need."
The test, which usually costs 55 dollars, is free to minorities through a program sponsored by the U.S. Navy. In addition, this year's drive has received private funds from Consolidated Electric Services, Novartis Pharmaceutical and Lucent Technologies to sponsor test for 30 to 40 non-minority donors.
"There are thousands of people who need a bond marrow transplant to survive," Harley said. "IT can save someone's life."
Want to keep up with breaking news? Subscribe to our email newsletter.